![Priya Marreddy](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Priya Marreddy
Director Técnico/Científico/I+D en CONTEXT THERAPEUTICS INC. .
Perfil
Priya Marreddy is currently the Vice President-Clinical Operations at Context Therapeutics, Inc. Previously, she worked as the Head-Clinical Operations at Cornerstone Pharmaceuticals, Inc. She completed her graduate degree at the University of Pennsylvania and her undergraduate degree at George Washington University.
Cargos activos de Priya Marreddy
Empresas | Cargo | Inicio |
---|---|---|
CONTEXT THERAPEUTICS INC. | Director Técnico/Científico/I+D | 01/04/2022 |
Antiguos cargos conocidos de Priya Marreddy.
Empresas | Cargo | Fin |
---|---|---|
Cornerstone Pharmaceuticals, Inc.
![]() Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | Director Técnico/Científico/I+D | - |
Formación de Priya Marreddy.
George Washington University | Undergraduate Degree |
University of Pennsylvania | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
CONTEXT THERAPEUTICS INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Cornerstone Pharmaceuticals, Inc.
![]() Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | Commercial Services |
- Bolsa de valores
- Insiders
- Priya Marreddy